Xlife Sciences AG (XSWX:XLS) Change In Other Working Capital: CHF-2.57 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:XLS Xlife Sciences AG XSWX:XLS
35 GF Score
Price CHF12.85
GF Value CHF8.43
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Xlife Sciences AG Change In Other Working Capital?

Xlife Sciences AG XSWX:XLS +2.80% 35 Change In Other Working Capital is CHF-2.57 Mil as of Jun. 2025. GuruFocus rates XSWX:XLS with a GF Score™ of 35/100 and a GF Value™ of CHF8.43 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Xlife Sciences AG's Change In Other Working Capital for the quarter that ended in Jun. 2025 was CHF-0.01 Mil. It means Xlife Sciences AG's Other Working Capital declined by CHF0.01 Mil from Dec. 2024 to Jun. 2025 .

Xlife Sciences AG's Change In Other Working Capital for the fiscal year that ended in Dec. 2025 was CHF5.66 Mil. It means Xlife Sciences AG's Other Working Capital increased by CHF5.66 Mil from Dec. 2024 to Dec. 2025 .

Xlife Sciences AG Change In Other Working Capital Historical Data

* Premium members only.

The historical data trend for Xlife Sciences AG's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xlife Sciences AG Change In Other Working Capital Chart

Xlife Sciences AG Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Other Working Capital
Get a 7-Day Free Trial -0.88 -1.11 3.62 -2.88 5.66

Xlife Sciences AG Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Change In Other Working Capital Get a 7-Day Free Trial -0.10 3.72 -0.31 -2.57 -0.01
XSWX:XLS
35GF Score
Xlife Sciences AG XSWX:XLS
Change In Other Working Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xlife Sciences AG Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-2.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Change In Other Working Capital of CHF-2.57 Mil mean?
Xlife Sciences AG (XSWX:XLS) has a Change In Other Working Capital of CHF-2.57 Mil as of Jun. 2025. Change In Other Working Capital is any increase or decrease between periods of other working capital. View historical data on Xlife Sciences AG and its competitors.
Is Xlife Sciences AG's Change In Other Working Capital too high?
Xlife Sciences AG's current Change In Other Working Capital is CHF-2.57 Mil. Overall, Xlife Sciences AG has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xlife Sciences AG's Change In Other Working Capital compare to VRTX and REGN?
Xlife Sciences AG's Change In Other Working Capital of CHF-2.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Other Working Capital for a Biotechnology company?
A good Change In Other Working Capital depends on the Biotechnology industry context. However, Change In Other Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Other Working Capital mean?
A high Change In Other Working Capital can signal that a stock is expensive relative to its fundamentals. Change In Other Working Capital is any increase or decrease between periods of other working capital. View historical data on Xlife Sciences AG and its competitors. Xlife Sciences AG's current Change In Other Working Capital is CHF-2.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xlife Sciences AG stock overvalued right now?
Based on GuruFocus' analysis, Xlife Sciences AG (XSWX:XLS) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF8.43, compared to a current price of CHF12.85 — trading 52.4% above its estimated fair value. The current Change In Other Working Capital is CHF-2.57 Mil. Xlife Sciences AG's overall GF Score™ is 35/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Other Working Capital calculated?
Change In Other Working Capital is calculated from a company's financial statements. For Xlife Sciences AG (XSWX:XLS), the current Change In Other Working Capital is CHF-2.57 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xlife Sciences AG (XSWX:XLS) Overvalued in 2026?

Based on GuruFocus' analysis, Xlife Sciences AG stock appears to be overvalued. The current stock price of CHF12.85 is trading 52.4% above its estimated GF Value™ of CHF8.43. GuruFocus considers Xlife Sciences AG to be Significantly Overvalued.

Key valuation signals for XSWX:XLS:

  • Change In Other Working Capital: CHF-2.57 Mil
  • GF Value™: CHF8.43 vs. price of CHF12.85 (52.4% above fair value)
  • GF Score™: 35/100 with 10 warning signs

No single metric tells the full story. See the XSWX:XLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xlife Sciences AG Business Description

Other Exchanges XLSz:UKXLS:Germany
Address Talacker 35, Zurich, CHE, 8001
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.
35GF Score

Get the complete analysis for XSWX:XLS

Change In Other Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF12.85
Price
CHF8.43
GF Value